Skip to search formSkip to main contentSkip to account menu

Insulin Glargine

Known as: INSULIN,GLARGINE,HUMAN/rDNA, Glargine, Insulin, Insulin, Glycyl(A21)-Arginyl(B31,B32) 
A recombinant human insulin analog with long-acting, blood glucose-lowering activity. Insulin glargine, like regular types of human insulin… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
In this 16-week, exploratory, open-label, parallel-group, two-period crossover study (clinicaltrials.gov identifier NCT01658579… 
Review
2010
Review
2010
The Diabetes Control and Complications Trial (DCCT) demonstrated the importance of optimal glycemic control achieved through… 
Review
2008
Review
2008
Context Bedtime insulin is a common strategy for improving glycemic control when type 2 diabetes is poorly controlled with oral… 
Review
2007
Review
2007
OBJECTIVE—We sought to assess health-related quality of life (HRQOL) in patients with type 2 diabetes treated with insulin… 
Highly Cited
2007
Highly Cited
2007
OBJECTIVES: To compare initiation of insulin therapy by adding once‐daily insulin glargine to oral antidiabetic agents (OADs… 
2004
2004
Aim of this 1-yr open parallel study was to evaluate the efficacy of two regimens of intensive insulin treatment: continuous s.c… 
2003
2003
The aim of this study was to compare the subcutaneous absorption characteristics of insulin glargine with NPH insulin in patients… 
2003
2003
Abstract:  The pediatric diabetes team at the University of Minnesota made a clinical decision to switch patients with type 1… 
Highly Cited
2002
Highly Cited
2002
The patient was a 37-year-old registered nurse recently followed during her second pregnancy complicated by diabetes. Type 1…